Tessera Defense and Homeland Security Inc.

Tessera Defense and Homeland Security Inc. (HLSQ) Stock Analysis

$0.134

+0.011 (+8.06%)At close

Loading chart…
High
0.147
Open
0.142
VWAP
0.14
Volume
310.94K
Mkt Cap
—
Low
0.130
Amount
42.61K
EV/EBITDA, TTM
0.00

Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers.

thlsq.ai

AI analysis of Tessera Defense and Homeland Security Inc. (HLSQ)

Sell

BiomX Inc is not a good buy right now due to its extremely low current price of 0.13, a staggering year-to-date change of -92.75%, and a very low RSI of 20.515 indicating oversold conditions. The company has reported zero revenue for multiple quarters, and its gross margin is only 29.22%. The main risk is its negative net income of -3,772,000 USD in the most recent quarter, which raises concerns about its financial viability.

Valuation Metrics

The current forward P/E ratio for Tessera Defense and Homeland Security Inc. (HLSQ) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

5Y Average EV/EBITDA
Current EV/EBITDA
0.00

Forward P/S

5Y Average P/S
Current P/S
0.00

Events Timeline

2026-10-20 (ET)

08:30:00

Zorronet Receives Initial Order from Global Defense Company

2026-10-15 (ET)

10:00:00

Tessera Defense Secures Option to Acquire Controlling Stake in RT LTA Systems

News

HLSQ FAQ — answered by Alphio AI

Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers.

BiomX Inc is not a good buy right now due to its extremely low current price of 0.13, a staggering year-to-date change of -92.75%, and a very low RSI of 20.515 indicating oversold conditions. The company has reported zero revenue for multiple quarters, and its gross margin is only 29.22%. The main risk is its negative net income of -3,772,000 USD in the most recent quarter, which raises concerns about its financial viability.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading